Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement.

Authors: Gagnier JJ (1) , Boon H (2) , Rochon P (3) , Moher D (4) , Barnes J (5) , Bombardier C (6) , CONSORT GROUP
(1) 5955 Ontario Street, Unit 307, Windsor (2) University of Toronto, Faculty of Pharmacy (3) Baycrest Centre, Toronto (4) Chalmers Research Group, Children's Hospital of Eastern Ontario Research Institute (5) Centre for Pharmacognosy and Phytotherapy, University of London School of Pharmacy (6) Institute for Work and Health, Toronto
Source: Ann Intern Med. 2006 Mar 7;144(5):364-7.
DOI: 10.7326/0003-4819-144-5-200603070-00013 Publication date: March 7, 2006 E-Publication date: Not specified Availability: abstract Copyright: © 2006, The American College of Physicians
Language: English Countries: Not specified Location: Not specified Correspondence address: Joel J. Gagnier, ND, MSc,
5955 Ontario Street, Unit 307, Windsor, Ontario N81S W6, Canada
E-mail :


Article abstract

Herbal medicinal products are widely used, vary greatly in content and quality, and are actively tested in randomized, controlled trials (RCTs). The authors' objective was to develop recommendations for reporting RCTs of herbal medicine interventions, based on the need to elaborate on the 22-item CONSORT (Consolidated Standards of Reporting Trials) checklist. Telephone calls were made and a consensus meeting was held with 16 participants in Toronto, Canada, to develop these recommendations. The group agreed on context-specific elaborations of 9 CONSORT checklist items for RCTs of herbal medicines. Item 4, concerning the herbal medicine intervention, required the most extensive elaboration. These recommendations have been developed to improve the reporting of RCTs using herbal medicine interventions.

Find it online